Patents and Publications

Patents

  • Direct Granules with a combination of retarded and fast releasing magnesium.
    G. Weiss, J. Haala, W. Schiemenz, EP Application EP 3 922 243 A2
    from October 4th, 2021
    EP000003922243A2
  • Liquid omega-3 fatty acid compositions for direct oral administration.
    G. Weiss, V. Garsuch, W. Schiemenz, EP Application 1 920 3420.
    from October 15th, 2019
    PCT/WO/2021/074118 from October 13th, 2020
    WO002021074118A1
  • Method for producing a pharmaceutical composition comprising proton pump inhibitors.
    G. Weiss, T. Profitlich, K. Schwitzer, C. Wagner, M. Schwitzer, B. Huber, EP 2 645 996 B1
    (WO 2012/072570) from March 2nd, 2016.
    EP2645996
  • Stable drug form for oral administration with benzimidazole derivatives as active ingredients and process for the preparation thereof.
    G.-U. Heese, H. Jünger, A. Laicher, C. Lorck, T. Profitlich, G. Weiß, US Patent US 6,623,759 B2 from September 23rd, 2003.
    US6623759
  • Stabile Arzneiform mit Benzimidazolderivaten als Wirkstoff zur oralen Verabreichung und Verfahren zu ihrer Herstellung.
    G.-U. Heese, H. Jünger, A. Laicher, C. Lorck, T. Profitlich, G. Weiß, Europäische Patentschrift
    EP 0 934 058 B1 from August 20th, 2003.
    EP0934058

The owners of the patents are indicated on the patents.

Image Description

Publications

  • Investigation on a cost effective, non-sticking direct compression method for ibuprofen.
    P. Matthias, G. Weiß, F. Knott, T. Profitlich, W. Frieß, 7th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Valleta, Malta (2010).
    Publ1
  • Microencapsulation of the renin inhibitor FK906 by phase separation of ethylcellulose in cyclohexane.
    G. Weiß, H. Yamaguchi, R. Ibuki, M. Yasumura, N. Ohnishi, J. Microencaps. 15 (3), 335 - 346 (1998).
    Publ2
  • Pharmacokinetik characteristics of a new liquid sustained release formulation of theophylline / microcaps as sachet.
    W.S. Fuchs, G. Weiß, A. v. Nieciecki, A. Laicher, S. Gay, G. Pabst, M. Müller, Arzneim. Forsch. / Drug Res. 48 (I), 612 - 617 (1998).
    Publ3
    >> http://www.clinpharmacol.com
  • Manufacture and in vitro characterization of a new liquid theophylline sustained release dosage form / sachets with microcapsules for the preparation of a ready-to-use sustained release suspension.
    G. Weiß, F. Klemm, W.S. Fuchs, F. Stanislaus, M. Zema, M. Calanchi, Arzneim. Forsch. / Drug Res. 48 (I), 604 - 612 (1998).
    Publ4
  • The effect of different variables on the in vitro dissolution of a sustained release theophylline preparation.
    W.S. Fuchs, R. Jakobs, P. Grunenberg, G. Weiß, T. Profitlich, A. v. Nieciecki, F. Klemm, A. Laicher, F. Stanislaus, Arzneim.-Forsch. / Drug Res. 48 (I), 552 - 556 (1998).
    Publ5
  • Concepts for realization of GMP compliant manufacture; semisolid dosage forms.
    G. Weiß, APV - Kurs “Klinische Prüfpräparate – Herstellung und Qualitätssicherung”, Freiburg – Munzingen, Germany (1996).
  • Pharmacokinetic characteristics of a new liquid sustained release formulation of theophylline designed for the elderly and children: Microcaps as sachet.
    W. S. Fuchs, G. Weiß, A. v. Nieciecki, A. Laicher, G. Pabst, M. Müller, Int. J. Clin. Pharmacol. Therap. 34, 558 - 563 (1996).
    Publ6
    >> http://www.clinpharmacol.com
  • Pharmacokinetics of ibuprofen following a single administration of a suspension containing enteric coated microcapsules.
    K. Walter, G. Weiß, A. Laicher, F. Stanislaus, Arzneim. Forsch. / Drug Res. 45 (8), 886 - 890 (1995).
    Publ7
  • Simple coacervation of hydroxypropyl methylcellulose phthalate (HPMCP),
    II: Microencapsulation of ibuprofen.
    G. Weiß, A. Knoch, A. Laicher, F. Stanislaus, R. Daniels, Int. J. Pharm. 124, 97 - 105 (1995).
    Publ8
  • Simple coacervation of hydroxypropyl methylcellulose phthalate (HPMCP),
    I: Temperature and pH dependency of coacervate formation.
    G. Weiß, A. Knoch, A. Laicher, F. Stanislaus and R. Daniels, Int. J. Pharm. 124, 87 - 96 (1995).
    Publ9
  • Scale-up considerations in microencapsulation of ibuprofen by simple coacervation of cellulose acetate phthalate (CAP) and cellulose acetate trimellitate (CAT).
    G. Weiß and A. Knoch, 7th Annual Meeting Slowenian Pharmaceutical Society, Ljubljana, Slovenia (1995).
    Publ10
  • Microencapsulation of ibuprofen by a coacervation process using Eudragit L100-55 as an enteric polymer.
    G. Weiß, A. Knoch, A. Laicher, F. Stanislaus, R. Daniels, Drug Dev. Ind. Pharm. 19 (20), 2751 - 2764 (1993).
    Publ11
  • Influence of polymer charge density on the simple coacervation of cellulose acetate phthalate.
    G. Weiß, A. Knoch, A. Laicher, F. Stanislaus, R. Daniels, Eur. J. Pharm. Biopharm. 39 (6), 239 - 243 (1993).
    Publ12